News about "Bayer"

Tata Elxsi Opens Global Radiology Tech Hub for Bayer

The centre will serve as a global innovation hub, combining Tata Elxsi’s engineering expertise with India’s healthcare ecosystem to accelerate Bayer’s radiology solutions across key markets, including the US and EU.

Bayer | 12/09/2025 | By Dineshwori

Bayer Launches Bayer Co.Lab AdVenture Platform in China

Bayer launches Co.Lab AdVenture to connect biotech startups with global VCs, accelerating early-stage innovation through its lifesciences incubator network.

Bayer | 11/09/2025 | By Dineshwori

Bayer Expands Global Life Sciences Incubator With Launch Of Co.Lab AdVenture

Bayer has launched Co.Lab AdVenture, a new platform under its global life sciences incubator network, designed to connect high-potential biotech start-ups with leading venture capital partners worldwide.

Bayer | 09/09/2025 | By Darshana

US FDA Accepts Gadoquatrane for Review: Bayer

Bayer has submitted New Drug Application (NDA) for low dose contrast agent gadoquatrane to seek approval for contrast-enhanced Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) and other body regions for adults and paediatric patients including neonates.

Bayer | 27/08/2025 | By Dineshwori

Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli

Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.

Bayer | 22/08/2025 | By Dineshwori

Bayer Seeks US FDA Approval of gadoquatrane for MRI of CNS and Other Body Parts

Bayer has submitted a New Drug Application to the US FDA for gadoquatrane, an investigational MRI contrast agent. If approved, it would offer the lowest gadolinium dose among macrocyclic GBCAs in the US, cutting exposure by 60 percent while maintaining diagnostic efficacy.

Bayer | 18/06/2025 | By Abha

Bayer and Evotec to Upgrade Precision Cardiology

Bayer and Evotec have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).

Bayer | 01/05/2024 | By Aishwarya |  297

Dr Reddy's, Bayer to Market Second Brand of Vericiguat in India

Dr Reddy’s Laboratories has joined forces with Bayer to introduce a second brand of Vericiguat, a medication for chronic heart failure, to the Indian market.

Bayer | 08/04/2024 | By Aishwarya |  921

Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility

The manufacturing facility is located in Cleveland, Tennessee

Bayer | 21/12/2022 | By Sudeep Soparkar |  1014

Bayer starts $43.6 M expansion of Pennsylvania plant

The project will boost the plant’s packaging and production areas by 70,000 square feet

Bayer | 05/12/2022 | By Sudeep Soparkar |  548